Genoss Co., Ltd.
Clinical trials sponsored by Genoss Co., Ltd., explained in plain language.
-
New stent aims to keep heart patients alive longer
Disease control ENROLLING_BY_INVITATIONThis study is testing a new stent called GENOSS DES in 1000 adults with multiple blocked heart arteries. The stent is placed during a procedure to open the blockages. Researchers will track patients for up to a year to see if the stent prevents heart-related death, heart attacks,…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
New balloon could keep heart stents open longer
Disease control ENROLLING_BY_INVITATIONThis study compares a new drug-coated balloon (Genoss SCB) to an existing one (SeQuent Please NEO) for people whose heart stents have narrowed again. About 94 adults with this condition will be randomly assigned to receive one of the two balloons during a standard procedure. The …
Phase: NA • Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
New stent under observation for heart attack patients
Disease control OngoingThis study looks at how well a new stent called GENOSS SES works in people with acute coronary syndrome, a serious heart condition. About 757 participants are being observed in real-world medical settings. The goal is to see if the stent helps prevent heart-related death, heart a…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 11:49 UTC
-
New balloon treatment aims to keep leg arteries open
Disease control ENROLLING_BY_INVITATIONThis study looks at how well a special balloon coated with paclitaxel works for people with narrowed leg arteries. About 200 adults will be followed for a year to see if the balloon keeps the artery open and prevents the need for repeat procedures. The goal is to improve blood fl…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 11:35 UTC
-
New stent study aims to improve heart disease outcomes
Disease control OngoingThis study looks at how well a special drug-coated stent (GENOSS SES) works and how safe it is for people with blocked heart arteries. About 1,118 adults who already received this stent are being followed to track heart-related events like heart attack or the need for another pro…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New heart stent under study: could it improve artery treatment?
Disease control ENROLLING_BY_INVITATIONThis study is testing a new type of stent (a small mesh tube) coated with a drug that slowly releases to keep heart arteries open. About 1,000 adults with coronary artery disease who need a stent will be enrolled. Researchers will track how well the stent works and its safety ove…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New balloon treatment could unclog tiny heart arteries without surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a special balloon coated with a drug (paclitaxel) and natural ingredients (shellac and vitamin E) to treat narrowed small heart arteries. About 3000 adults with new blockages in small arteries will receive this balloon treatment during a standard procedure. The g…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New balloon treatment for leg artery disease shows promise in Real-World study
Disease control ENROLLING_BY_INVITATIONThis study is following 300 people who had a procedure to open blocked leg arteries using a special balloon coated with a drug (paclitaxel) and vitamin E. The goal is to see if the balloon keeps the arteries open for at least a year without major problems like amputation or needi…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC